Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases

(2011) Gerhard J. Molderings et al.   INTERNAL MEDICINE

Evidence for Mast Cell Activation in Patients with Therapy-Resistant Irritable Bowel Syndrome

(2011) T. Frieling et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients

(2010) K. Brockow et al.   ALLERGY

Systemic mastocytosis and bone involvement in a cohort of 75 patients

(2010) S. Barete et al.   ANNALS OF THE RHEUMATIC DISEASES

Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations

(2010) Y. Yang et al.   BLOOD

How I treat patients with advanced systemic mastocytosis

(2010) P. Valent et al.   BLOOD

Biological implications of preformed mast cell mediators

(2010) Anders Lundequist et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Mastocytosis and insect venom allergy

(2010) Patrizia Bonadonna et al.   Current Opinion in Allergy and Clinical Immunology

Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects

(2010) Gerhard J. Molderings et al.   IMMUNOGENETICS

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes

(2010) Cristina Teodosio et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms

(2010) Iván Álvarez-Twose et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Mast cell activation syndrome: Proposed diagnostic criteria

(2010) Cem Akin et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

New aspects of liver abnormalities as part of the systemic mast cell activation syndrome

(2010) Kirsten Alfter et al.   LIVER INTERNATIONAL

Die systemische Mastozytose – Standortbestimmung einer internistischen Erkrankung

(2010) Jürgen Homann et al.   MEDIZINISCHE KLINIK

Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine

(2009) Ken H. Lim et al.   AMERICAN JOURNAL OF HEMATOLOGY

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

(2009) K.-H. Lim et al.   BLOOD

Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients

(2009) Luis Escribano et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations

(2009) Christine Bodemer et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

(2009) Arturo Vega-Ruiz et al.   LEUKEMIA RESEARCH

Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics

(2009) Gerhard J. Molderings et al.   UROLOGICAL RESEARCH

Phase II Study of Dasatinib in Philadelphia Chromosome-Negative Acute and Chronic Myeloid Diseases, Including Systemic Mastocytosis

(2008) S. Verstovsek et al.   CLINICAL CANCER RESEARCH

Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis

(2008) David González de Olano et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis

(2008) Olivier Hermine et al.   PLoS One